Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
23.50
18.73
26.05
24.60
16.82
24.73
32.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
23.50
18.73
26.05
24.60
16.82
24.73
32.88
Raw Material Cost
12.49
10.37
18.05
16.43
10.63
16.90
24.13
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
1.02
2.59
-0.21
-0.20
-0.18
-0.85
-2.68
Employee Cost
3.59
4.26
4.32
4.36
4.17
4.44
4.58
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.00
-0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
3.72
4.20
3.82
3.38
2.90
6.39
4.57
Total Expenditure (Excl Depreciation)
20.83
21.42
25.98
23.96
17.52
26.88
30.60
Operating Profit (PBDIT) excl Other Income
2.67
-2.69
0.07
0.64
-0.70
-2.15
2.28
Other Income
0.17
0.16
0.12
0.09
0.65
-0.27
0.35
Operating Profit (PBDIT)
2.84
-2.53
0.19
0.73
-0.05
-2.42
2.63
Interest
2.18
1.93
1.89
1.94
2.42
2.00
2.18
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
0.66
-4.46
-1.70
-1.21
-2.47
-4.42
0.45
Depreciation
1.77
1.51
1.52
1.53
1.42
1.96
1.74
Profit Before Tax
-1.10
-5.96
-3.21
-2.73
-3.89
-6.38
-1.29
Tax
0.28
-1.21
-0.27
-0.73
-1.83
-1.19
0.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-1.38
-4.75
-2.95
-2.01
-2.06
-5.19
-2.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-1.38
-4.75
-2.95
-2.01
-2.06
-5.19
-2.09
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-1.38
-4.75
-2.95
-2.01
-2.06
-5.19
-2.09
Equity Capital
13.06
13.06
13.06
13.06
13.06
13.06
13.06
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
-1.06
-3.64
-2.26
-1.54
-1.58
-3.97
-1.6
Diluted Earnings per share
-1.07
-3.6
-2.24
-1.52
-1.56
-3.98
-1.53
Operating Profit Margin (Excl OI)
11.36%
-14.36%
0.27%
2.6%
-4.16%
-8.69%
6.93%
Gross Profit Margin
2.81%
-23.81%
-6.53%
-4.92%
-14.68%
-17.87%
1.37%
PAT Margin
-5.87%
-25.36%
-11.32%
-8.17%
-12.25%
-20.99%
-6.36%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 39.71% vs -55.55% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 33.01% vs 43.56% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 481.43% vs -120.83% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -9.92% vs -36.98% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of ANG Lifesciences With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
23.50
0
23.50
Other Operating Income
0.00
0.00
0.00
Total Operating income
23.50
0
23.50
Raw Material Cost
12.49
0
12.49
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
1.02
0
1.02
Employee Cost
3.59
0
3.59
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
3.72
0.00
3.72
Total Expenditure (Excl Depreciation)
20.83
0
20.83
Operating Profit (PBDIT) excl Other Income
2.67
0.00
2.67
Other Income
0.17
0
0.17
Operating Profit (PBDIT)
2.84
0
2.84
Interest
2.18
0
2.18
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
0.66
0
0.66
Depreciation
1.77
0
1.77
Profit Before Tax
-1.10
0
-1.10
Tax
0.28
0
0.28
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-1.38
0
-1.38
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
-1.38
0
-1.38
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-1.38
0
-1.38
Equity Capital
13.06
0
13.06
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
-1.06
0
-1.06
Diluted Earnings per share
-1.07
0
-1.07
Operating Profit Margin (Excl OI)
11.36%
0%
0.00
11.36%
Gross Profit Margin
2.81%
0%
0.00
2.81%
PAT Margin
-5.87%
0%
0.00
-5.87%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 23.50 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 25.47% vs -28.10% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 39.71% vs -55.55% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit -1.38 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 70.95% vs -61.02% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 33.01% vs 43.56% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.67 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 199.26% vs -3,942.86% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 481.43% vs -120.83% in Mar 2025
Quarterly - Interest
Interest 2.18 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 12.95% vs 2.12% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -9.92% vs -36.98% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.36%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
